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 Abstract 
 
 
 
Enantiomeric 2,3,4-tris(hydroxyalkyl)-5-phenylpyrrolidines have been synthesized from 
the major cycloadducts obtained by the 1,3-dipolar cycloaddition of sugar enones with 
azomethine ylides derived from natural amino acids. Reduction of the ketone carbonyl 
group of the cycloadducts, which possess a basic structure of bicyclic 6-
menthyloxyhexahydropyrano[4,3-c]pyrrol-7(6H)one, afforded a number of pyrrolidine-
based bicyclic systems. A sequence of reactions, which involved hydrolysis of the 
menthyloxy substituent, reduction, N-protection and degradative oxidation, afforded 
varied pyrrolidine structures having diverse configurations and patterns of substitution, 
particularly polyhydroxylated derivatives have been obtained. The unprotected products 
were isolated as pyrrolidinium trifluoroacetates. Because of the furanose-like nature of 
the target trihydroxyalkyl pyrrolidines, these molecules have been evaluated as 
inhibitors of the β-galactofuranosidase from Penicillium fellutanum. The compounds 
showed practically no inhibitory activity for concentration of pyrrolidines in the range 
of 0.1 to 1.6 mM. 
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 Introduction 
The increasing interest in polyhydroxypyrrolidines relies on their potential in the 
treatment of diseases. Polyhydroxypyrrolidines are also known as azasugars or 
iminosugars as they are mimics of sugars in which the ring oxygen atom has been 
replaced by a nitrogen atom. The most valuable properties of these compounds is their 
ability to inhibit glycosidases. These enzymes catalyze the cleavage of glycosidic 
linkages and are involved in a wide range of important biological events, including the 
processing of oligosaccharide chains of oligosaccharides, bacterial and viral infections 
and tumor metastasis.
1
 The glycosidase inhibitors have shown to be effective for the 
treatment of varied pathologies,
2
 and the scope is constantly increased.
3
 Thus, alkaloidal 
sugar mimics are currently employed or are potential drugs for the treatment of type II 
diabetes, for the modulation of the immune response, in cancer therapy, as anti-infective 
and antiviral agents, in the development of novel therapeutics for lysosomal storage 
diseases, in the chaperone-mediated therapy, etc.
4 
The inhibitory activity of glycosidases and glycosyltransferases by azasugars is 
attributed to the fact that, at physiological pH, the nitrogen atom is protonated and this 
charged species mimics the oxacarbenium transition state formed during glycosidase 
hydrolysis and glycosyl transfer.
5
 Moreover, azasugar transition state analogues proved 
to be useful tools for the study of the mechanism of action of carbohydrate-processing 
enzymes.
6
 
Alkaloids mimicking the structure of monosaccharides are believed to be widespread in 
plants and microorganisms.
7
 Particularly, polyhydroxylated pyrrolidines with varied 
arrangements of at least two hydroalkyl groups as substituent of the five-membered 
heterocyclic ring have been isolated first from Derris elliptica,
8
 and later from many 
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disparate species of plants and microorganisms,
9
 indicating that they are rather common 
metabolites. These type of pyrrolidines have also been isolated from seeds of 
Angylocalyx pinaerty
8
 and from the leaves or bulbs of different species of Hyacintus
10,11 
and Hyacinthaceae.
10,12 
The synthesis of pyrrolidines, including those with hydroxyalkyl substituents in the 
ring, has been recently reviewed.
13
 Some recent syntheses of this type of molecules 
have been reported.
14 
As continuation of our project on the synthesis of sugar mimetics as inhibitors of 
glycosidases,
15 
we report here the synthesis of enantiomeric pyrrolidines substituted in 
three adjacent positions of the ring with hydroxyalkyl groups. These compounds were 
obtained by chemical transformations performed on cycloadducts generated by 1,3-
dipolar cycloaddition of azomethine ylides and sugar enones.
16
 Some representative 
compounds were evaluated as inhibitors of the β-galactofuranosidase from Penicillium 
fellutanum. We are seeking for inhibitors of this enzyme as some pathogenic 
microorganisms, including  mycobacteria, fungus (Aspergillus and Penicillium species) 
and protozoa (Trypanosoma and Leishmania), display β-galactofuranosidase activity.
17
 
The inhibition of enzymes involved in the metabolism of galactofuranose, which is 
absent in higher eukaryotes, is expected to prevent the proliferation of pathogens such 
as Mycobacterium tuberculosis or Trypanosoma cruzi, the respective agents of 
tuberculosis or Chagas disease. Furthermore, as the structure and interactions in the 
catalytic site of the enzyme remain unknown, the development of new inhibitors can 
contribute to the understanding of the processes triggered by galactofuranose processing 
enzymes. 
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 Results and discussion 
The 1,3-dipolar cycloaddition is one of the most powerful tools for the synthesis of 
heterocyclic scaffolds and the reaction has been applied in diverse fields like drug 
discovery, polymers and materials.
18
 We have employed the 1,3-dipolar cycloaddition 
reaction of stabilized azomethine ylides and sugar-derived enones (1a and 1b) to afford 
cycloadducts of the type of 2a or 2b, as shown in Scheme 1.
16
 The stereogenic center 
(S) or (R) of the sugar pyranone (1a or 1b, respectively) exerts a strict diastereocontrol 
during the [3+2]-cycloaddition. Thus, the menthyloxy substituent of such a stereocenter 
is axially-oriented because of the anomeric effect, and induces the approach of the 
dipole from the opposite face of the pyranone ring. This remarkable selectivity was also 
observed for Diels-Alder cycloadditions and other additions to the double bond of 
enones of the type of 1a or 1b.
19
  Therefore, the pyrrolidine ring of the major product 
endo-2a, obtained from (S)-1a, had the opposite configuration for the four stereocenters 
generated during the cycloaddition than those of endo-2b, obtained from (R)-1b.  
 
Scheme 1: Enantiomeric pyrrolidines (endo isomers) obtained from enones 1a (S) or 1b 
(R) via 1,3-dipolar cycloaddition. 
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Now, we were able to confirm by X ray crystallography the structure of compounds 2a 
and 2b, which had been previously assigned on the basis of NMR data.
16
 Suitable 
crystals of 2a and 2b could be obtained using acetonitrile as recrystallization solvent, 
and the X-ray diffraction analysis confirmed the absolute configuration assigned to 
these two key cycloadducts (Figure 1). In fact, the crystallographic data (fully described 
in the Supporting Information) reveals that compound 2a crystalizes as a solvate with 
one molecule of acetonitrile, while two independent molecules of 2b occupy the 
asymmetric unit (Z = Z’ = 2). 
 
Figure 1: Drawing of molecules 2a and 2b showing the displacement ellipsoids of non-
H atoms at 50% probability levels. 
 
 
 
Starting from 1a or 1b a number of cycloadducts (2a−2f) have been prepared and they 
were subjected to a sequence of reduction and hydrolysis reactions in order to obtain 
enantiomerically pure polyhydroxypyrrolidines of varied configurations. In first 
instance, the reduction of the carbonyl group of 2a−2f was studied (Scheme 2). The 
reaction was conducted with sodium borohydride in ethanol at 0 °C, except when the 
dissolution of the starting compound requires a slightly higher temperature (25 °C). 
Anyway, the reduction of 2a was completed after 10−30 min to afford two main 
products, which were separated by column chromatography. The minor component of 
Page 6 of 43
ACS Paragon Plus Environment
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
the mixture was identified as 3a, which resulted from the attack of the hydride from the 
Si face of the carbonyl. The resulting alcohol underwent spontaneous lactonization by 
nucleophilic attack to the ethyl carboxylate conveniently located, to give 3a. The major 
product of the reduction was the epimeric alcohol 4a (84%), having 7S configuration. 
Scheme 2: Reduction of ketone carbonyl for cycloadducts 2a-2f. 
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 The structure of 3a and 4a was established on the basis of the NMR data, including the 
NOE interactions observed. Some relevant NMR information is shown in Figure 2. For 
example, the formation of the lactone ring induces a downfield shifting of the H-7 
signal in 3a, compared with that of 4a, and H-7 correlates with the carboxylate carbon 
in the HMBC spectrum of 3a.  
 
Figure 2: Significant NMR data for assignment of the structure of compounds 3a and 
4a. NOE contacts are shown in red. 
 
 
 
Reduction of endo-2b, under the conditions employed for the diasteroisomer endo-2a, 
led also to the lactone 3b and the alcohol 4b (major product). Other adducts having 
diverse structures, were also reduced under similar conditions (0 to 25 °C for 10-30 
min) to give alcohols with 7S configuration. Thus, endo-2c that carries at C-1 a 3’-
pyridyl group instead of a phenyl group as 2a, was reduced to  the alcohol 3c as the only 
isolated product (82% yield). Similarly, the exo adducts 2d and 2e led to, although in 
somewhat lower yield compared to endo-compounds, the respective 3d and 3e, without 
isolation of the epimeric alcohols of configuration 7R. 
The diasteroselectivity observed for the reduction of 2a−2e could be attributed to the 
axial orientation of the bulky menthyloxy substituent because of the anomeric effect, as 
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clearly shown for 2a and 2b in the crystalline state (Figure 1). This group induces the 
approach of the hydride from the opposite face, to give the product with a syn 
relationship for the substituents of C-6 and C-7. However, the configuration of 
stereocenters of the pyrrolidine ring seems to affect the stereochemical course of the 
reaction, as the reduction of 2f was less diasteroselective. A distinctive structural fact 
between 2a−2e and 2f is the relative orientation of the substituents at C-1 and C-3 
vicinal to the nitrogen atom, which are trans in 2f and cis in the other precursors 2a−2e. 
The C-1 and C-3 substituents of the pyrrolidine ring in 2f are not able to be 
simultaneously quasi-equatorially oriented. A preliminary modeling of the structure of 
2f, using the AM1 semiempirical method, showed a tendency of the phenyl group at C-
3 to adopt a quasi-axial disposition. In this case, such a group should hinder the 
approach of hydride from this side. Therefore, the hindrance of both faces of the 
carbonyl group leads to the formation of a diasteroisomeric mixture of alcohols 3f and 
4f. 
The NaBH4 reduction of the endo cycloadducts 2a and 2c was conducted at room 
temperature for 16 h. As expected, in addition to the reduction of the carbonyl group the 
ethyl carboxylate was partially reduced to afford the diol compounds 5a and 5c. 
Although 5a and 5c were obtained in a rather low yield (39% and 25%, respectively) the 
reaction conditions were not optimized.  
The next step was the hydrolysis of the menthyl acetal of compounds 4a or 4b, which 
was performed with 2:1 trifluoroacetic acid (TFA)-water at 90 °C for ~1.5 h. Thus, 
hydrolysis of 4a afforded the hemiacetal 6a, being initially the isomer β (6R) the major 
product, which on standing in pyridine solution rapidly equilibrates to an inseparable 
∼1:1 α:β anomeric mixture (Scheme 3). However, the individual signals of the 
1
H and 
13
C NMR spectra (recorded in pyridine-d5) could be assigned using 2D NMR 
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experiments (see Experimental Section). The assignment of the configuration of the C-6 
stereocenter was rather difficult because of the distortion of the conformation of the 
tetrahydropyran ring fused to the pyrrolidine ring, with the resulting alteration in the 
coupling constant values. In addition, these values appeared averaged because of the 
conformational equilibrium of the tetrahydropyran ring, which is able to adopt two chair 
forms (
6
C3a and 
3a
C6), illustrated for the 6S stereoisomer. Fortunately, the detection of 
specific NOE contacts (H-6 with H-7a and H-6 with H-4), allowed us to assign as S the 
C-6 configuration of one of the isomers, since the R-counterpart did not show such NOE 
interactions. The equilibrium between the two chair forms 
6
C3a and 
3a
C6 for the pyran 
ring of 6(S)-6a, justifies the small values measured for J6,7 and J7,7a (both ~ 3.1 Hz) and 
the relatively large one for J3a,4 (7.1 Hz). 
 
Scheme 3: Hydrolysis of the acetal group of 4a and conformational equilibrium for 
(6S)-6a. 
 
 
The same hydrolysis procedure applied to 4b gave 6b. The purification of the polar 
compounds 6a and 6b by column chromatography on silica gel was rather difficult, 
therefore the less polar N-Boc derivatives of 7a and 7b were prepared (Scheme 4). The 
protection of the amino group was also required for further reactions applied to 7a or 
7b. The NMR spectra revealed that 7a was a 4:1 mixture of 6R:6S isomers (6S:6R for 
7b). In fact, the spectra of 7a and 7b are identical, as they are enantiomeric compounds. 
Such spectra, similar to those of other related N-Boc derivatives, exhibited the signal of 
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the tert-butyl group of N-Boc as a broad singlet, indicating restriction in the rotation of 
this group due to the hindrance caused by the substituents of the carbons vicinal to the 
pyrrolidine nitrogen atom.  
 
Scheme 4: Intermediate and final products obtained by reduction of 6a, 7a and 7b 
 
The bicyclic compound 7a was treated with NaBH4 in EtOH at 0 °C for 1 h. The 
reduction product was isolated by column chromatography as a homogenous syrup, 
which was shown to be a mixture by NMR analysis. The spectra revealed the absence of 
the ethyl group of the ester of 7a, but a carboxylate carbon (174.4 ppm) suggested the 
formation of a lactone (8a). The lactonization of a methyl ester with a conveniently 
located vicinal hydroxymethyl group in a pyrrolidine ring has been described.
20
 In the 
case of 7a, the reduction of the hemiacetal should release a hydroxymethyl group, 
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conveniently located for the lactonization with the ethyl ester to give 8a. Separation of 
the mixture was achieved upon acetylation, which led to the per-O-acetyl derivatives of 
the lactone (10a) and the lactol (11a). The correlation in the HMBC spectrum of 10a 
between the lactone carbonyl (172.6 ppm) and one of the C-4 methylene protons 
confirmed the formation of the lactone ring. The 
1
H NMR spectrum of 10a showed a 
broadening of the signals of the tert-butyl group of the N-Boc and those of the protons 
vicinal to the N-Boc, H-2 and H-6a. The signal broadening is typical due to a slow 
exchange regime in the conformational equilibrium of the urethane group. 
The location of the lactol function of 11a was confirmed on the basis of the HMBC 
spectrum, which showed correlation of the acetal proton H-6 with C-3a and C-4. The 
presence of two anomeric protons (H-6) in the 
1
H NMR spectrum of 11a suggested a 
diastereomeric mixture of hemiacetals. However, the fact that each H-6 appeared as a 
singlet, in spite of the presence of a proton in the adjacent carbon (C-6a), and the 
duplicated signals of the N-Boc tert-butyl group, H-2 and H-6a led us to suspect that the 
molecule was populating two conformations.
21
 Beyond the signal broadening in the 
lactone 10a, in the case of 11a the signals of the same protons, which corresponded to 
each rotamer, were clearly separated. Probably, the crowded environment of the 
nitrogen in the bicyclic system of 11a prevents the free rotation of the Boc substituent, 
giving rise to two detected conformers in ~1.6 : 1 ratio. This fact was confirmed by the 
NOESY spectrum of 11a, which clearly showed exchange peaks between the 
corresponding pairs of H-2, H-6a and tert-butyl
 
signals from each rotamer. As observed 
for slow exchange systems, the pair of peaks were of the same sign as the diagonal 
peaks, while the NOE cross-peaks are of opposite sign compared to the diagonal 
peaks.
22
 As an additional confirmation of equilibrium between rotamers, the selective 
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irradiation at the resonance frequency of each tert-butyl signal led to the disappearance 
of the other one (See Supporting information). 
The configuration of the C-6 stereocenter was assigned as R, since a NOE contact 
between H-6 and phenyl protons was detected. This should be the favored configuration 
as the acetoxy group is attached to the less hindered face of the oxacyclopentane, 
opposite to the fused pyrrolidine ring. 
Reduction of 7b under the same conditions, followed by acetylation, afforded the 
lactone 10b and lactol 11b, the enantiomeric counterparts of 10a and 11a, respectively. 
The ratio of lactone/lactol formed was rather difficult to control. The product 
distribution proved to be particularly sensitive to the reaction time. For example, NaBH4 
reduction of 7b at 0 °C for 30 min led, after acetylation, to lactone 10b as a major 
product.  
On the other hand, the reduction of both the hemiacetal and the ester functionalities of 
7a could be performed on treatment with NaBH4 (3mol/mol 7a) in anhydrous EtOH at 
80 °C, to afford the polyhydroxyalkylpyrrolidine 12a in 82% yield. Acetylation of crude 
12a led to the per-O-acetyl derivative 13a. The same reactions applied to 7b afforded 
12b, which was per-O-acetylated to 13b. The absolute value of the optical rotation and 
the opposite sign of 12a and 12b, as well as their identical 
1
H and 
13
C NMR spectra, 
confirmed that these pairs of compounds are enantiomeric. In order to obtain the 
unprotected pyrrolidine 14, the adduct 6a was reduced at 80 °C, as already described for 
7a and 7b, to afford the pyrrolidine 14. The 
1
H NMR spectrum of 14 admitted a first 
order analysis. Therefore, many NOE interactions could be observed; those between H-
5 and H-2, H-3 and H-4, and H-2 with H-4 were in agreement with the all-cis 
disposition of the protons of the pyrrolidine ring. As an additional confirmation, NOE 
contacts between the protons of the phenyl group with H-1’ and with the CH2-3’ were 
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detected. Furthermore, protection of the amino group of 14 as the N-Boc derivative led 
to 12a. 
Treatment of 12a with TFA led to the removal of the tert-butyloxycarbonyl (Boc) group 
to afford the corresponding pyrrolidinium trifluoroacetate (15a). The same reaction 
applied to 12b afforded the corresponding salt 15b, the enantiomer of 15a (Scheme 5). 
Compounds 15a and 15b are fully unprotected phenyl substituted pyrrolidines which 
possess a hydroxyalkyl group on each of the other three adjacent stereocenters of the 
ring. 
 
Scheme 5: Synthesis of tri(hydroxyalkyl)pyrrolidines 15a, 15b, 18a and 18b. 
 
 
The 1,2-ethanediol moiety linked at C-4 of 12a was subjected to degradative oxidation 
with sodium periodate. The resulting aldehyde function spontaneously reacts with the 
vicinal hydroxymethyl group to give the furanoid hemiacetal 16a. The HMBC spectrum 
of 16a showed the correlation of the hemiacetal carbon (C-1) with the CH2-3, H-3a, 6, 
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and 6a; while C-3 correlates with H-1 and H-4, confirming the formation of the furan 
ring. The absolute configuration of C-1 was established on the basis of the small value 
for the coupling constant J1,6a (2.1 Hz), Characteristic of 1,2-trans furanoses, and also 
the observed NOE interactions of H-1 with H-6, 6a and protons of the phenyl group, in 
agreement with the R configuration for C-1. Other NOE contacts (H-4 with H-6 and H-
6a, H-3x with H-6a, H-3a with H-6) confirmed the structure proposed. 
Reduction of the hemiacetal derivatives 16a or 16b with NaBH4 afforded the respective 
tris(hydroxymethyl) pyrrolidines 17a or 17b. The 
1
H NMR spectra of 17a and 17b 
showed a broad signal for the N-Boc tert-butyl group, but the signal of the vicinal 
protons to the N-Boc (H-2 and H-5) appeared well resolved. The relatively large values 
for the coupling constant between the protons of the pyrrolidine ring (J2,3, J3,4 and J4,5 ~ 
7.8−7.9 Hz) suggested an envelope conformation with the N atom below the plane 
formed by the ring carbon atoms. The NOESY spectrum of 17a showed NOE 
interactions of the phenyl group with all the protons of the hydroxymethyl groups (CH2-
1’, 3’ and 4’). 
Removal of the N-Boc group of 17a with TFA led to the pyrrolidinium trifluoroacetate 
18a. The NMR spectra of this compound showed a similar behavior to that of 17a. 
Hence, a similar conformation could be expected. Interestingly, the trifluoroacetate 
anion showed two quartets due to the carboxylate (162.4 ppm, J = 36.0 Hz) and 
trifluoromethyl (116.0 ppm, J = 291.0 Hz).   
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Evaluation of the inhibitory activity of selected pyrrolidines against a β-
galactofuranosidase. 
Because of the furanoid nature of the pyrrolidines, a furanosidase (the β-D-
galactofuranosidase from P. fellutanum) was selected as model enzyme for the 
inhibition studies. The natural substrate for the exo β-D-galactofuranosidase is the 
extracellular peptide phosphogalactomannan from P. fellutanum. This glycopeptide 
contains terminal (1→5)-linked β-D-galactofuranose units, attached to a α-mannose 
core.
23
 The enzyme, which is not commercially available, has been isolated from the 
culture growth of the fungus.
24
  
The pyrrolidines 14, 15a, 15b, 18a and 18b were evaluated as inhibitors of the enzyme. 
To determine the inhibitory activity of the compounds we employed 4-nitrophenyl β-D-
galactofuranoside as substrate of the enzyme and the protocol previously established 
was followed.
15b
 The inhibitory profile was compared with those of the known inhibitor 
galactono-1,4-lactone (Ki = 0.10 mM).
15b 
Compounds 14, 15a, 15b, 18a and 18b were 
subjected to the enzymatic reaction, in concentrations ranging from 0.1 to 1.6 mM. 
Releasing of 4-nitrophenol was employed as a measurement of galactofuranosidase 
activity. Unfortunately, none of the compounds revealed a noticeable inhibitory activity 
even at high concentrations (1.6 mM). The activity of the enzyme was reported to be 
highly sensitive to steric factors (size of substituents of the furanose ring) in the 
inhibitor.
25
 Probably the presence of the phenyl group and the additional carbon atoms 
of pyrrolidines 14, 15a, 15b, 18a and 18b, compared to galactofuranosides, could 
introduce steric hindrance hampering their accommodation within the active site of the 
enzyme. The configurations of the stereocenters of the evaluated molecules may also 
play a decisive role on the activity.  
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Conclusions 
The cycloadducts obtained by the 1,3-dipolar cycloaddition reaction of sugar enones 
with azomethine ylides have been converted, via simple reactions, into a number of 
pyrrolidines with varied configurations and patterns of substitution. Enantiomeric 
pyrrolidines having four stereocenters of defined configuration have been prepared. The 
formation of enantiomers was defined by the stereochemistry of the acetal function of 
the starting sugar-derived enone. Thus, reduction of the carbonyl of the bicyclic 6-
menthyloxyhexahydropyrano[4,3-c]pyrrol-7(6H)-ones followed by hydrolysis of the 
menthyl acetal afforded hemiacetal-ester derivatives, which were reduced with NaBH4. 
The reaction conditions were adjusted for selective reduction of the hemiacetal function 
or both, the hemiacetal and ester groups, to afford a variety of 
polyhydroxyalkylpyrrolidines. Selective protection of the amino function of such 
compounds, followed by oxidative degradation of a 1,2-diol (glycol) system and 
reduction led to polyhydroxymethylpyrrolidines via an effective and simple 
methodology. The resulting 2,3,4-tris(hydroxymethyl)-5-phenylpyrrolidines were not 
active as inhibitors of the β-galactofuranosidase from P. fellutanum. However, these 
compounds may well serve as example for the systematic drug design. Further studies 
on the inhibitory activity of the compounds will be conducted with other enzymes 
(glycosidases or glycosyltransferases) which proved to be inhibited by pyrrolidines 
structurally related to those described here.
2e,14a
 Furthermore, other possible biological 
activities
2-4
 for the new compounds will be explored as well as their potential use in 
asymmetric organocatalysis,
26
 since enantiomeric pairs of pyrrolidines are available. 
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Experimental Section 
 
General procedure for the reduction of adducts 2a−2e. 
The cycloadduct 2a−2e
16
 (1.00 mmol) was dissolved in anhydrous EtOH (15 mL). In 
some cases, smooth heating was necessary to achieve complete dissolution. The 
resulting solution was allowed to reach room temperature and placed in a bath at 0 °C or 
25 °C. Upon addition of NaBH4 (1.50 mmol) the mixture was stirred at 0 °C or 25 °C 
for 10−30 min, when TLC (hexane:EtOAc, 1:1) showed disappearance of the starting 
material, and formation of lower moving products. The reaction was neutralized with 
AcOH and concentrated. The residue was redissolved in EtOH (20 mL) followed by 
evaporation of the solvent. After the same treatment with toluene (20 mL), the residue 
was purified by column chromatography, with solvent indicated in each particular case. 
As the by-products were obtained in small amounts, the yields reported are 
approximate. 
 
Reduction of Ethyl (1R,3S,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2a). 
The general procedure applied to the reduction (at 25 °C) of cycloadduct 2a (247 mg, 
0.56 mmol) afforded compounds 3a and 4a, which were separated by column 
chromatography (hexane:EtOAc, 85:15). 
(1R,3S,3aR,6S,7R,7aS)-7-hydroxy-6-(-)-menthyloxy-1-phenyloctahydropyrano[4,3-
c]pyrrole-3-carboxylic acid 3,7-lactone (3a): white solid (9.4 mg, 4%), mp = 134−136 
°C (from EtOH); Rf = 0.64 (hexane:EtOAc, 1:1), [α]  −52.8 (c 1.2, CHCl3); 
1
H NMR 
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(CDCl3, 500 MHz) δ 7.45−7.25 (5H, H-aromatic), 4.87 (d, 1H, J6,7 = 2.7 Hz, H-6), 4.83 
(d, 1H, J1,7a = 5.4 Hz, H-1), 4.19 (dd, 1H, J3a,4ax = 3.1, J4ax,4eq = 12.2 Hz, H-4ax), 3.94 
(d, 1H, J4ax,4eq = 12.2 Hz, H-4eq), 3.87 (d, 1H, J3,3a = 4.2 Hz, H-3), 3.67 (dd, 1H, J6,7 = 
3.8, J7,7a = 2.7 Hz, H-7), 3.47 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 2.89 (m, 1H, 
J1,7a = 5.4, J3a,7a = 1.8, J7,7a = 3.8 Hz, H-7a), 2.50 (m, 1H, H-3a), 2.24 (ddd, 1H, H 
menthyl), 1.94 (m, 1H, H menthyl), 1.66−1.61 (m, 2H, H menthyl), 1.32−1.22 (m, 2H, 
H menthyl), 0.97−0.80 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 171.6 
(CO2-lactone), 139.2−127.1 (C-aromatic), 93.0 (C-6), 75.7 (C-1 menthyl), 74.4 (C-7), 
63.7 (C-1), 60.7 (C-3), 57.9 (C-4), 48.1 (C-menthyl), 42.2 (C-3a), 39.8 (C-menthyl), 
38.1 (C-7a), 34.5, 31.4, 25.6, 22.9, 22.3, 21.4, 15.6 (C-menthyl); HRMS (ESI) m/z [M + 
Na]
+
 calcd for C24H33NNaO4 422.2302, found 422.2326. 
Ethyl (1R,3S,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (4a): colorless syrup (208 mg, 
84%); Rf = 0.56 (hexane:EtOAc, 1:1), [α]  −57.6 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ 7.49−7.23 (5H, H-aromatic), 4.87 (brs, 1H, OH), 4.68 (d, 1H, J6,7 = 1.4 Hz, H-
6), 4.47 (d, 1H, J1,7a = 5.1 Hz, H-1), 4.31 (m, 2H, OCH2CH3), 4.10 (d, 1H, J3,3a = 11.3 
Hz, H-3), 4.09 (dd, 1H, J3a,4ax = 4.7, J4ax,4eq = 12.5 Hz, H-4ax), 3.89 (dd, 1H, J3a,4eq = 1.7, 
J4ax,4eq = 12.5 Hz, H-4eq), 3.38 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 3.25 (br s, 
1H, H-7), 2.76 (m, 1H, J3,3a = 11.3, J3a,4ax = 4.7, J3a,4eq = 1.7, J3a,7a = 7.0 Hz, H-3a), 2.69 
(dddd, 1H, J1,7a = 5.1, J3a,7a = 7.0, J7,7a = 4.5 Hz, H-7a), 2.26 (m, 1H, H menthyl), 1.99 
(m, 1H, H menthyl), 1.64−1.59 (m, 2H, H menthyl), 1.35 (t, 3H, J = 7.1 Hz, OCH2CH3), 
1.27−1.18 (m, 2H, H menthyl), 0.96−0.76 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 
125.7 MHz) δ 173.7 (CO2Et), 138.2−126.8 (C-aromatic), 96.0 (C-6), 74.7 (C-1 
menthyl), 65.7 (C-7), 64.6 (C-1), 61.6 (OCH2CH3), 59.2 (C-3), 56.1 (C-4), 48.2, 39.8 
(C-menthyl), 39.3 (C-3a), 39.0 (C-7a), 34.5, 31.4, 25.4, 23.0, 22.4, 21.4, 15.8 (C-
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menthyl), 14.4 (OCH2CH3); HRMS (ESI) m/z [M + H]
+
 calcd for C26H40NO5 446.2901, 
found 446.2922. 
 
Reduction of Ethyl (1S,3R,3aS,6R,7aR)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2b). 
The general reduction procedure (at 25 °C) applied to cycloadduct 2b (100 mg, 0.23 
mmol) afforded compounds 3b and 4b. 
(1S,3R,3aS,6R,7S,7aR)-7-hydroxy-6-(-)-menthyloxy-1-phenyloctahydropyrano[4,3-
c]pyrrole-3-carboxylic acid 3,7-lactone (3b): colorless syrup (6 mg, 6 %); Rf = 0.64 
(hexane:EtOAc, 1:1); [α]  −37.1 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 
7.43−7.26 (5H, H-aromatic), 4.81 (d, 1H, J1,7a = 5.5 Hz, H-1), 4.71 (d, 1H, J6,7 = 2.7 Hz, 
H-6), 4.27 (dd, 1H, J3a,4ax = 3.0, J4ax,4eq = 12.2 Hz, H-4ax), 3.92 (d, 1H, J4ax,4eq = 12.2 Hz, 
H-4eq), 3.86 (d, 1H, J3,3a = 4.5 Hz, H-3), 3.71 (dd, 1H, J6,7 = 2.7, J7,7a = 3.8 Hz, H-7), 
3.29 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 2.94 (dt, 1H, J1,7a = 5.5, J3a,7a ~ 2.0, 
J7,7a = 3.8 Hz, H-7a), 2.48 (dddd, 1H, J3,3a = 4.5, J3a,4ax = 3.0, J3a,7a ~ 2.0 Hz, H-3a), 2.12 
(m, 1H, H menthyl), 1.81 (m, 1H, H menthyl), 1.65−1.55 (m, 2H, H menthyl), 1.36 (m, 
1H, H menthyl), 1.18 (m, 1H, H menthyl), 0.93−0.60 (m, 12H, H menthyl); 
13
C NMR 
(CDCl3, 125.7 MHz) δ 171.7 (CO2-lactone), 139.2−127.0 (C-aromatic), 98.5 (C-6), 81.2 
(C-1 menthyl), 73.7 (C-7), 63.5 (C-1), 60.7 (C-3), 57.9 (C-4), 48.7, 43.1 (C-menthyl), 
42.3 (C-3a), 38.1 (C-7a), 34.3, 31.7, 26.0, 23.5, 22.3, 21.0, 16.5 (C-menthyl); HRMS 
(ESI) m/z [M + H]
+
 calcd for C24H34NO4 400.2482, found 400.2473.  
Ethyl (1S,3R,3aS,6R,7R,7aR)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (4b): white solid (87 mg, 87%); 
mp = 163−164 °C (from EtOH:H2O); Rf = 0.56, hexane:EtOAc, 1:1; [α]  −19.4 (c 1.0, 
CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 7.48−7.24 (5H, H-aromatic), 4.53 (s, 1H, H-6), 
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4.46 (d, 1H, J1,7a = 5.0 Hz, H-1), 4.31 (m, 2H, OCH2CH3), 4.20 (dd, 1H, J3a,4ax = 5.0, 
J4ax,4eq = 12.5 Hz, H-4ax), 4.10 (d, 1H, J3,3a = 11.3 Hz, H-3), 3.87 (d, 1H, J4ax,4eq = 12.5 
Hz, H-4eq), 3.33 (d, 1H, J7,7a = 3.5 Hz, H-7), 3.23 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 
menthyl), 2.76 (dddd, 1H, J3,3a = 11.3, J3a,4ax = 5.0, J3a,7a = 5.7 Hz, H-3a), 2.68 (m, 1H, 
J1,7a = 5.0, J3a,7a = 5.7, J7,7a = 3,5 Hz, H-7a), 2.11 (m, 1H, H menthyl), 1.95 (m, 1H, H 
menthyl), 1.64−1.54 (m, 2H, H menthyl), 1.34 (t, 4H, H menthyl, OCH2CH3), 1.16 (m, 
1H, H menthyl), 0.90−0.62 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 
173.8 (CO2Et), 138.2−126.8 (C-aromatic), 102.2 (C-6), 80.6 (C-1 menthyl), 65.3 (C-7), 
64.6 (C-1), 61.6 (OCH2CH3), 59.2 (C-3), 56.3 (C-4), 48.9, 43.0 (C-menthyl), 39.2 (C-
3a), 39.0 (C-7a), 34.4, 31.8, 25.5, 23.3, 22.4, 21.2, 16.3 (C-menthyl), 14.4 (OCH2CH3); 
HRMS (ESI) m/z [M + H]
+
 calcd for C26H40NO5 446.2901, found 446.2900. 
 
Reduction of Ethyl (1R,3S,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-(pyridine-3-
yl)octahydropyrano[4,3-c]pyrrole-3-carboxylate (2c).  
The general procedure applied to the reduction (at 0 °C) of cycloadduct 2c (100 mg, 
0.22 mmol) led, after column chromatography (hexane:EtOAc, 3:7), to compound 3c 
(82 mg, 82%). 
Ethyl (1R,3S,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-1-(pyridine-3-
yl)octahydropyrano[4,3-c]pyrrole-3-carboxylate (3c): colorless syrup; Rf = 0.19 
(EtOAc); [α]  −52.3 (c 0.9, CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 8.62 (d, 1H, J = 1.5 
Hz, H-2’Py), 8.46 (dd, 1H, J = 1.1, 4.8 Hz, H-6’Py), 7.92 (dt, 1H, J = 1.1, 7.9 Hz, H-
4’Py), 7.26 (dd, 1H, J = 4.8, 7.9 Hz, H-5’Py), 4.66 (d, 1H, J6,7 < 1.0 Hz, H-6), 4.47 (d, 
1H, J1,7a = 4.9 Hz, H-1), 4.31 (m, 2H, OCH2CH3), 4.11 (d, 1H, J3,3a = 10.8 Hz, H-3), 
4.09 (dd, 1H, J3a,4ax = 4.8, J4ax,4eq = 12.6 Hz, H-4ax), 3.84 (d, 1H, J4ax,4eq = 12.6 Hz, H-
4eq), 3.35 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 3.19 (dd, 1H, J6,7 < 1.0, J7,7a = 
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2.9 Hz, H-7), 2.74 (m, 2H, H3a, H-7a), 2.22 (m, 1H, H menthyl), 1.97 (m, 1H, H 
menthyl), 1.63−1.57 (m, 2H, H menthyl), 1.34 (t, 3H, J = 7.1 Hz, OCH2CH3), 1.29−1.16 
(m, 2H, H menthyl), 0.88−0.69 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 
174.3 (CO2Et), 148.9−123.2 (C-aromatic), 96.0 (C-6), 74.9 (C-1 menthyl), 65.6 (C-7), 
62.7 (C-1), 61.9 (OCH2CH3), 59.3 (C-3), 55.8 (C-4), 48.2 (C-menthyl), 39.8, 39.5, 39.1 
(C-3a, 7a, menthyl), 34.5, 31.4, 25.4, 23.0, 22.3, 21.4, 15.8 (C-menthyl), 14.4 
(OCH2CH3). HRMS (ESI) m/z [M + H]
+
 calcd for C25H39N2O5 447.2853, found 
447.2873.  
 
Reduction of Ethyl (1S,3R,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2d). 
The cycloadduct 2d (100 mg, 0.23 mmol) was reduced (at 0 °C) according to the 
general procedure to afford 3d, which was isolated by column chromatography 
(hexane:EtOAc, 92:8). 
Ethyl (1S,3R,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (3d): colorless syrup (70 mg, 
70%); Rf = 0.28 (hexane:EtOAc, 8:2), [α]  −153.5 (c 0.9, CHCl3); 
1
H NMR (CDCl3, 
500 MHz) δ 7.50−7.21 (5H, H-aromatic), 5.01 (d, 1H, J6,7 = 3.9 Hz, H-6), 4.59 (d, 1H, 
J1,7a = 1.0 Hz, H-1), 4.26 (m, 2H, OCH2CH3), 4.05 (d, 1H, J3,3a = 10.2 Hz, H-3), 3.96 
(dd, 1H, J3a,4ax = 3.6, J4ax,4eq = 12.2 Hz, H-4ax), 3.77 (dd, 1H, J3a,4eq = 1.3, J4ax,4eq = 12.2 
Hz, H-4eq), 3.66 (dd, 1H, J6,7 = 3.9, J7,7a = 9.4 Hz, H-7), 3.50 (ddd, 1H, J = 4.1, J = 10.7 
Hz, H-1 menthyl), 2.40 (m, 1H, J3,3a = 10.2, J3a,4ax = 3.6, J3a,4eq = 1.3, J3a,7a = 4.1 Hz, H-
3a), 2.18−2.12 (m, 3H, H menthyl, H-7a), 1.69−1.63 (m, 2H, H menthyl), 1.38 (m, 1H, 
H menthyl), 1.32 (t, 3H, J = 7.1 Hz, OCH2CH3), 1.26 (m, 1H, H menthyl), 0.94−0.74 
(m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 174.6 (CO2Et), 145.3−126.5 (C-
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aromatic), 93.5 (C-6), 75.7 (C-1 menthyl), 67.8 (C-7), 64.5 (C-1), 61.3 (OCH2CH3), 
60.7 (C-3), 57.7 (C-4), 51.2 (C-7a), 48.3 (C-menthyl), 40.8 (C-3a), 40.4, 34.5, 31.6, 
25.4, 22.9, 22.4, 21.3, 15.4 (C-menthyl), 14.4 (OCH2CH3). HRMS (ESI) m/z [M + Na]
+ 
calcd for C26H39NNaO5 468.2720, found 468.2718. 
 
Reduction of Ethyl (1R,3S,3aS,6R,7aR)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2e). 
Reduction (at 0 °C) of 2e (100 mg, 0.23 mmol) led to 3e, which was purified by column 
chromatography (hexane:EtOAc, 85:15). 
Ethyl (1R,3S,3aS,6R,7R,7aR)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (3e): colorless syrup (70 mg, 
70%); Rf = 0.40 (hexane:EtOAc, 7:3); [α]  +92.9 (c 0.8, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ 7.49−7.21 (5H, H-aromatic), 4.90 (d, 1H, J6,7 = 3.3 Hz, H-6), 4.58 (br s, 1H, 
J1,7a ~ 0 Hz, H-1), 4.26 (m, 2H, OCH2CH3), 4.03 (d, 1H, J3,3a = 10.0 Hz, H-3), 4.01 (dd, 
1H, J3a,4ax = 3.6, J4ax,4eq = 12.2 Hz, H-4ax), 3.78 (dd, 1H, J3a,4eq = 1.4, J4ax,4eq = 12.2 Hz, 
H-4eq), 3.64 (dd, 1H, J6,7 = 3.3, J7,7a = 9.4 Hz, H-7), 3.39 (ddd, 1H, J = 4.1, J = 10.7 Hz, 
H-1 menthyl), 2.39 (m, 1H, J3,3a = 10.0, J3a,4ax = 3.6, J3a,4eq = 1.4, J3a,7a = 3.5 Hz, H-3a), 
2.21−2.16 (m, 2H, H menthyl, H-7a), 2.12 (m, 1H, H menthyl), 1.66−1.60 (m, 2H, H 
menthyl), 1.40 (m, 1H, H menthyl), 1.26 (m, 1H, H menthyl), 1.31 (t, 3H, J = 7.1 Hz, 
OCH2CH3), 0.94−0.76 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 174.7 
(CO2Et), 145.3−126.4 (C-aromatic), 99.4 (C-6), 81.2 (C-1 menthyl), 68.7 (C-7), 64.6 
(C-1), 61.3 (OCH2CH3), 60.8 (C-3), 57.8 (C-4), 51.5 (C-7a), 48.8, 43.1 (C-menthyl), 
41.0 (C-3a), 34.3, 31.8, 25.8, 22.9, 22.4, 21.3, 15.6 (C-menthyl), 14.4 (OCH2CH3). 
HRMS (ESI) m/z [M + H]
+ 
calcd for C26H40NO5 446.2901, found 446.2902. 
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Reduction of Ethyl (1R,3R,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2f). 
Reduction of 2f
16
 (100 mg, 0.23 mmol) according to the general procedure (at 0 °C) 
afforded compounds 3f and 4f, which were separated by column chromatography 
(hexane:EtOAc, 92:8). 
Ethyl (1R,3R,3aR,6S,7R,7aS)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (3f): colorless syrup (26 mg, 
26%); Rf = 0.54 (hexane:EtOAc, 8:2); [α]  −70.3 (c 0.8, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ 7.55−7.23 (5H, H-aromatic), 4.87 (d, 1H, J6,7 = 4.3 Hz, H-6), 4.68 (d, 1H, J1,7a 
= 4.0 Hz, H-1), 4.23 (m, 2H, OCH2CH3), 4.11 (dd, 1H, J3a,4ax = 3.0, J4ax,4eq = 12.0 Hz, H-
4ax), 4.00 (d, 1H, J3,3a = 8.6 Hz, H-3), 3.94 (dddd, 1H, J6,7 = 4.3, J7,7a = 9.1, J7,OH = 7.6 
Hz, H-7), 3.78 (d, 1H, J4ax,4eq = 12.0 Hz, H-4eq), 3.43 (ddd, 1H, J = 4.1, J = 10.7 Hz, H-
1 menthyl), 2.46 (dddd, 1H, J3,3a = 8.6, J3a,4ax = 3.0, J3a,7a = 6.4 Hz, H-3a), 2.44 (dddd, 
1H, J1,7a = 4.0, J3a,7a = 6.4, J7,7a = 9.1 Hz, H-7a), 2.29 (m, 1H, H menthyl), 2.02 (m, 1H, 
H menthyl), 1.66−1.61 (m, 2H, H menthyl), 1.31 (t, 3H, J = 7.1 Hz, OCH2CH3), 
1.26−1.24 (m, 2H, H menthyl), 1.03 (d, 1H, J2,OH = 7.6 Hz, OH), 0.93−0.79 (m, 12H, H 
menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 176.0 (CO2Et), 141.0−127.0 (C-aromatic), 
93.5 (C-6), 75.9 (C-1 menthyl), 65.0 (C-1), 64.0 (C-7), 61.4 (OCH2CH3), 59.6 (C-3), 
58.0 (C-4), 48.1 (C-menthyl), 46.9 (C-7a), 44.3 (C-3a), 40.2, 34.5, 31.5, 25.5, 22.9, 
22.3, 21.3, 15.5 (C-menthyl), 14.4 (OCH2CH3). HRMS (ESI) m/z [M + Na]
+
 calcd for 
C26H39NNaO5 468.2720, found 468.2721. 
Ethyl (1R,3R,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (4f): colorless syrup (49 mg, 
49%); Rf = 0.25 (hexane:EtOAc, 8:2); [α]  −55.0 (c 0.8, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ 7.44−7.24 (5H, H-aromatic), 4.76 (d, 1H, J6,7 = 1.6 Hz, H-6), 4.71 (d, 1H, J1,7a 
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= 4.6 Hz, H-1), 4.26 (m, 2H, OCH2CH3), 4.14 (dd, 1H, J3a,4ax = 4.2, J4ax,4eq = 12.3 Hz, 
H-4ax), 4.11 (d, 1H, J3,3a = 8.8 Hz, H-3), 3.94 (d, 1H, J4ax,4eq = 12.3 Hz, H-4eq), 3.46 
(ddd, 1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 3.29 (dd, 1H, J6,7 = 1.6, J7,7a = 4.1 Hz, H-
7), 2.71 (dt, 1H, J1,7a = 4.6, J3a,7a = 6.0, J7,7a = 4.1, Hz, H-7a), 2.36 (m, 1H, J3,3a = 8.8, 
J3a,4ax = 4.2, J3a,7a = 6.0 Hz, H-3a), 2.27 (m, 1H, H menthyl), 2.03 (m, 1H, H menthyl), 
1.66−1.60 (m, 2H, H menthyl), 1.34−1.21 (m, 2H, H menthyl), 1.33 (t, 3H, J = 7.1 Hz, 
OCH2CH3), 0.96−0.80 (m, 12H, H menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 175.2 
(CO2Et), 138.2−126.5 (C-aromatic), 95.0 (C-6), 75.0 (C-1 menthyl), 66.0 (C-7), 64.9 
(C-1), 61.6 (OCH2CH3), 60.4 (C-3), 57.9 (C-4), 48.2 (C-menthyl), 41.2 (C-3a), 40.4 (C-
7a), 39.9, 34.6, 31.4, 25.5, 23.0, 22.4, 21.4, 15.8 (C-menthyl), 14.4 (OCH2CH3). HRMS 
(ESI) m/z [M + H]
+ 
calcd for C26H40NO5 446.2901, found 446.2914. 
 
Reduction of Ethyl (1R,3S,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-
phenyloctahydropyrano[4,3-c]pyrrole-3-carboxylate (2a) or Ethyl 
(1R,3S,3aR,6S,7aS)-7-oxo-6-(-)-menthyloxy-1-(pyridine-3-yl)octahydropyrano[4,3-
c]pyrrole-3-carboxylate (2c) with NaBH4/EtOH (25 °C, 16 h).  
The cycloadduct 2a (100 mg, 0.23 mmol) was dissolved in anhydrous EtOH (4 mL) and 
NaBH4 (12 mg, 0.33 mmol) was added. The reaction was stirred at 25 °C for 16 h and 
stopped upon addition of AcOH. Monitoring by TLC (EtOAc) showed the formation of 
a polar product (Rf = 0.23), which after the usual work up, was isolated by column 
chromatography (EtOAc).  
The same procedure applied to 2c (100 mg, 0.22 mmol) led to 5c, which was purified by 
column chromatography using CH2Cl2:MeOH, 95:5 as solvent.  
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(1R,3S,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-3-hydroxymethyl-1-
phenyloctahydropyrano[4,3-c]pyrrolidine (5a): colorless syrup (36 mg, 39%); [α]  
−53.0 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 7.40−7.24 (5H, H-aromatic), 4.67 
(d, 1H, J6,7 = 1.8 Hz, H-6), 4.47 (d, 1H, J1,7a = 4.8 Hz, H-1), 4.13 (dd, 1H, J3,3’a = 7.4, 
J3’a,3’b = 11.5 Hz, H-3’a), 4.07 (dd, 1H, J3a,4ax = 5.1, J4ax,4eq = 12.7 Hz, H-4ax), 3.97 (dd, 
1H, J3,3’b = 4.7, J3’a,3’b = 11.5 Hz, H-3’b), 3.77 (d, 1H, J4ax,4eq = 12.7 Hz, H-4eq), 3.73 
(dddd, 1H, J3,3a = 11.1, J3,3’a = 7.4, J3,3’b = 4.7 Hz, H-3), 3.37 (ddd, 1H, J = 4.1, J = 10.7 
Hz, H-1 menthyl), 3.27 (dd, 1H, J6,7 = 1.8, J7,7a = 4.2 Hz, H-7), 2.73 (dddd, 1H, J1,7a = 
4.8, J3a,7a = 7.4, J7,7a = 4.2 Hz, H-7a), 2.52 (m, 1H, J3,3a = 11.1, J3a,4ax = 5.1, J3a,7a = 7.4 
Hz, H-3a), 2.24 (m, 1H, H menthyl), 1.96 (m, 1H, H menthyl), 1.64−1.59 (m, 2H, H 
menthyl), 1.31−1.19 (m, 2H, H menthyl), 0.93−0.77 (m, 12H, H menthyl); 
13
C NMR 
(CDCl3, 125.7 MHz) δ 136.8−126.5 (C-aromatic), 95.3 (C-6), 75.0 (C-1 menthyl), 65.2 
(C-7), 63.5 (C-1), 62.2 (C-3’), 58.9 (C-3), 56.0 (C-4), 48.2, 39.8 (C-menthyl), 38.7 (C-
7a), 35.5 (C-3a), 34.5, 31.4, 25.4, 23.0, 22.3, 21.4, 15.7 (C-menthyl). HRMS (ESI) m/z 
[M + H]
+
 calcd for C24H38NO4 404.2795, found 404.2814.  
(1R,3S,3aR,6S,7S,7aS)-7-hydroxy-6-(-)-menthyloxy-3-hydroxymethyl-1-(pyridine-
3-yl)octahydropyrano[4,3-c]pyrrolidine (5c): colorless syrup (22 mg, 25%), Rf = 0.44 
(CH2Cl2:MeOH, 9:1); [α]  −38.0 (c 1.2, CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 8.63 
(br s, 1H, H-2’Py), 8.46 (d, 1H, J = 4.8 Hz, H-6’Py), 7.81 (d, 1H, J = 7.9 Hz, H-4’Py), 
7.29 (dd, 1H, J = 4.8, 7.9 Hz, H-5’Py), 4.71 (s, 1H, H-6), 4.49 (d, 1H, J1,7a = 4.7 Hz, H-
1), 4.13 (dd, 1H, J3,3’a = 7.0, J3’a,3’b = 11.7 Hz, H-3’a), 4.09 (dd, 1H, J3a,4ax = 5.0, J4ax,4eq = 
12.8 Hz, H-4ax), 3.97 (dd, 1H, J3,3’b = 4.2, J3’a,3’b = 11.7 Hz, H-3’b), 3.79 (d, 1H, J4ax,4eq 
= 12.8 Hz, H-4eq), 3.73 (m, 1H, J3,3a = 10.0, J3,3’a = 7.0, J3,3’b = 4.2 Hz, H-3), 3.38 (ddd, 
1H, J = 4.1, J = 10.7 Hz, H-1 menthyl), 3.23 (d, 1H, J7,7a = 3.5 Hz, H-7), 2.77 (dddd, 
1H, J1,7a = 4.7, J3a,7a = 8.1, J7,7a = 3.5 Hz, H-7a), 2.56 (dddd, 1H, J3,3a = 10.0, J3a,4ax = 
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5.0, J3a,7a = 8.1 Hz, H-3a), 2.24 (m, 1H, H menthyl), 1.98 (m, 1H, H menthyl), 
1.65−1.60 (m, 2H, H menthyl), 1.32−1.20 (m, 2H, H menthyl), 0.94−0.75 (m, 12H, H 
menthyl); 
13
C NMR (CDCl3, 125.7 MHz) δ 148.3−123.5 (C-aromatic), 95.4 (C-6), 75.2 
(C-1 menthyl), 65.2 (C-7), 62.5 (C-3’), 61.5 (C-1), 58.9 (C-3), 56.0 (C-4), 48.2, 39.8 
(C-menthyl), 38.8 (C-7a), 35.6 (C-3a), 34.5, 31.5, 25.5, 23.0, 22.4, 21.4, 15.7 (C-
menthyl). HRMS (ESI) m/z [M + H]
+
 calcd for C23H37N2O4 405.2748, found 405.2758. 
 
Hydrolysis of the menthyloxy acetal of 4a and 4b. 
A solution of 4a or 4b (1 mmol) in 2:1 TFA:H2O (12 mL) was heated at 90 °C in a 
sealed vial under static Ar atmosphere. When monitoring by TLC (hexane:EtOAc, 1:1) 
showed conversion of the starting material into a more polar product (~1.5 h), the 
solution was concentrated in vacuum. The residue was dissolved in water (20 mL) and 
the mixture concentrated to eliminate TFA and menthol. Then, toluene (20 mL) was 
added and removed by evaporation. The resulting syrup was purified by column 
chromatography (EtOAc:hexane, 9:1) to afford compound 6a or 6b (from 4a or 4b, 
respectively). 
Ethyl (1R,3S,3aR,7S,7aS)-6,7-dihydroxy-1-phenyloctahydropyrano[4,3-c]pyrrole-
3-carboxylate (6a): was obtained from 4a (114 mg, 0.26 mmol) as a colorless syrup (51 
mg, 65%); Rf = 0.30 (EtOAc). On standing in solution 6a equilibrates to a 1:1 anomeric 
mixture (α = 6S; β = 6R). 
1
H NMR (pyridine-d5, 500 MHz) δ 7.72−7.26 (10H, H-
aromatic), 5.45 (d, 1H, J6,7 = 1.6 Hz, H-6β), 5.02 (d, 1H, J6,7 = 3.1 Hz, H-6α), 4.64 (dd, 
1H, J3a,4 = 5.5, J4,4’ = 12.0 Hz, H-4β), 4.61 (d, 1H, J1,7a = 5.4 Hz, H-1β), 4.49 (d, 1H, 
J1,7a = 5.8 Hz, H-1α), 4.38 (d, 1H, J3,3a = 11.1 Hz, H-3β), 4.35 (dd, 1H, J3a,4 = 8.7, J4,4’ = 
11.3 Hz, H-4α), 4.30 (dd, 1H, J3a,4’ = 3.6, J4,4’ = 12.0 Hz, H-4’β), 4.29 (d, 1H, J3,3a = 10.5 
Hz, H-3α), 4.34−4.14 (m, 4H, OCH2CH3), 4.05 (dd, 1H, J3a,4’ = 7.1, J4,4’ = 11.3 Hz, H-
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4’α), 3.92 (t, 1H, J6,7 = J7,7a = 3.1 Hz, H-7α), 3.89 (dd, 1H, J6,7 = 1.6, J7,7a = 4.2 Hz, H-
7β), 3.19−3.14 (m, 2H, H-3aα, H-7aβ), 3.01 (m, 1H, H-3aβ), 2.62 (dddd, 1H, J1,7a = 5.8, 
J3a,7a = 8.3, J7,7a = 3.1 Hz, H-7aα), 1.21, 1.12 (2 t, 3H, J = 7.1 Hz, OCH2CH3),; 
13
C NMR 
(pyridine-d5, 125.7 MHz) δ 173.9, 172.8 (CO2Et), 140.6−124.3 (C-aromatic), 96.1 (C-
6β), 94.1 (C-6α), 67.5 (C-7β), 66.7 (C-7α), 64.8 (×2) (C-1α, 1β), 62.3 (C-4α), 61.5, 61.3 
(OCH2CH3), 61.0 (C-3α), 60.4 (C-3β), 57.3 (C-4β), 44.1 (C-7aα), 41.2, 39.9 (C-3aα, 
7aβ), 40.4 (C-3aβ), 14.8, 14.7 (OCH2CH3). HRMS (ESI) m/z [M + Na]
+
 calcd for 
C16H21NNaO5 330.1312, found 330.1311.  
Ethyl (1S,3R,3aS,7R,7aR)-6,7-dihydroxy-1-phenyloctahydropyrano[4,3-c]pyrrole-
3-carboxylate (6b): The same procedure described for the preparation of 6a was 
applied starting from 4b (18 mg, 0.04 mmol). Compound 6b was obtained as a 1:1 
anomeric mixture (8 mg, 64%); Rf = 0.30 (EtOAc) identical 
1
H and 
13
C spectra as 6a; 
HRMS (ESI) m/z [M + H]
+
 calcd for C16H22NO5 308.1492, found 308.1485.  
 
Ethyl (1R,3S,3aR,6,7S,7aS)-2-(tert-butyloxycarbonyl)-6,7-dihydroxy-1-
phenyloctahydropyrano[3,4-c]pyrrole-3-carboxylate (7a): The crude compound 6a, 
obtained by hydrolysis of 4a (53 mg, 0.12 mmol), was dried in vacuum (2 h) and then 
dissolved in anhydrous MeCN (2 mL) and Boc2O (26 mg, 0.12 mmol) and N(Et)3 (12 
mg, 0.12 mmol) were added. The mixture was stirred at room temperature overnight, 
when TLC showed a main product of Rf = 0.60 (EtOAc), which was isolated by column 
chromatography (hexane:EtOAc, 3:2) to afford foamy compound 7a (36 mg, 74%) as a 
4:1 mixture of 6R:6S isomers; [α]  +16.0 (c 0.9, CHCl3); 
1
H NMR (CDCl3, 500 MHz) 
(6R isomer) δ 7.35−7.20 (5H, H-aromatic), 5.09 (d, 1H, J1,7a = 6.8 Hz, H-1), 4.55 (d, 
1H, J3,3a = 10.7 Hz, H-3), 4.37 (d, 1H, J6,7 = 1.6 Hz, H-6), 4.32 (m, 2H, OCH2CH3), 4.17 
(dd, 1H, J3a,4’ = 1.0, J4,4’ = 13.0 Hz, H-4’), 3.78 (dd, 1H, J3a,4 = 4.7, J4,4’ = 13.0 Hz, H-4), 
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3.15 (dd, 1H, J6,7 = 1.6, J7,7a = 4.4 Hz, H-7), 2.82 (m, 1H, J1,7a = 6.8, J3a,7a = 8.0, J7,7a = 
4.4 Hz, H-7a), 2.77 (m, 1H, J3,3a = 10.7, J3a,4 = 4.7, J3a,4’ = 1.0, J3a,7a = 8.0 Hz, H-3a), 
1.35 (t, 3H, J = 7.1 Hz, OCH2CH3), 1.20 (br s, 9H, (CH3)3CO); 
13
C NMR (CDCl3, 125.7 
MHz) δ 174.4 (CO2Et), 155.1 (NCO2), 127.5−127.0 (C-aromatic), 95.2 (C-6), 81.1 
(C(CH3)), 65.9 (C-7), 65.1 (C-1), 62.5, 62.2, 61.9 (C-3, 4, OCH2CH3), 46.2 (C-7a), 37.9 
(C-3a), 28.0 (C(CH3)3), 14.3 (OCH2CH3); HRMS (ESI) m/z [M + Na]
+
 calcd for 
C21H29NNaO7 430.1836, found 430.1835. 
Ethyl (1S,3R,3aS,6,7R,7aR)-2-(tert-butyloxycarbonyl)-6,7-dihydroxy-1-
phenyloctahydropyrano[3,4-c]pyrrole-3-carboxylate (7b): The same procedure 
described for the preparation of 7a was applied starting from 4b (84 mg, 0.19 mmol). 
Compound 7b (61 mg, 79%) was obtained as a 4:1 mixture of 6S:6R isomers; [α]  
−17.9 (c 0.9, CHCl3); identical 
1
H and 
13
C spectra as 7a; HRMS (ESI) m/z [M + Na]
+
 
calcd for C21H29NNaO7 430.1836, found 430.1832. 
 
(2R,3S,3aR,6aS)-1-(tert-butyloxycarbonyl)-3-(1'(S),2'-diacetoxyethyl)-6-oxo-2-
phenylhexahydro-1H-furo[3,4-b]pyrrole (10a) and (2R,3S,3aR,6aS)-1-(tert-
butyloxycarbonyl)-3-(1'(S),2'-diacetoxyethyl)-6-acetoxy-2-phenylhexahydro-1H-
furo[3,4-b]pyrrole (11a)  
Compound 7a (34 mg, 0.08 mmol) was dissolved in anhydrous EtOH (1 mL) and 
NaBH4 (5 mg, 0.12 mmol) was added. The mixture was stirred at 0 °C for 1 h, when 
TLC (EtOAc) showed complete conversion of the starting material (Rf = 0.60) into a 
lower moving product (Rf = 0.20). The mixture was neutralized with AcOH and 
concentrated. The residue was redissolved in EtOH (10 mL) and the solvent evaporated. 
The resulting syrup was purified by column chromatography (hexane:EtOAc, 3:7) to 
afford an inseparable mixture of 8a and 9a (25 mg) isolated as a foam. The mixture was 
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acetylated by addition of anhydrous pyridine (2 mL) and acetic anhydride (2 mL) at 0 
°C. The solution was stirred for 16 h, when TLC (toluene: EtOAc, 7:3) showed 
complete conversion of the starting material into two new spots of Rf = 0.30 and 0.18. 
Upon addition of MeOH (10 mL), concentration and co-evaporation with toluene (20 
mL), the resulting mixture was subjected to column chromatography (toluene:EtOAc, 
95:5) to afford first the faster moving lactol 11a (13 mg, 32%, two steps) and then the 
lactone 10a (13 mg, 35%, two steps).  
Compound 10a: [α]  −42.6 (c 1.0, CHCl3); 
1
H NMR (CDCl3, 500 MHz) δ 7.36−7.14 
(5H, H-aromatic), 5.22 (d, 1H, J2,3 = 9.1 Hz, H-2), 5.11 (dt, 1H,  J1’,2’x = 4.1, J1’,2’y = 4.6, 
J1’,3 = 6.2 Hz, H-1’), 4.66 (d, 1xH, J3a,6a = 8.5 Hz, H-6a), 4.38 (dd, 1H, J1’,2’x = 4.1, 
J2’x,2’y = 12.1 Hz, H-2’x), 4.36 (dd, 1H, J3a,4x = 8.1, J4x,4y = 9.9 Hz, H-4x), 4.17 (t, 1H, 
J3a,4y = J4x,4y = 9.9 Hz, H-4y), 4.07 (dd, 1H, J1’,2’y = 4.6, J2’x,2’y = 12.1 Hz, H-2’y), 3.53 
(dddd, 1H, J3,3a = 7.2, J3a,4x = 8.1, J3a,4y = 9.9, J3a,6a = 8.5 Hz, H-3a), 3.02 (ddd, J1’,3 = 6.2, 
J2,3 = 9.1, J3,3a = 7.2 Hz, H-3), 2.09, 1.65 (2s, 6H, CH3CO), 1.40 (br s, 9H, (CH3)3CO); 
13
C NMR (CDCl3, 125.7 MHz) δ 172.6 (CO2-lactone), 170.5, 169.3 (MeCO), 153.8 
(NCO2), 129.2−126.3 (C-aromatic), 81.7 (C(CH3)), 68.5 (C-1’), 67.2 (C-4), 64.0 (×2) 
(C-2, 2’), 59.4 (C-6a), 44.2 (C-3), 41.6 (C-3a), 28.2 (C(CH3)3), 20.9, 20.5 (CH3CO); 
HRMS (ESI) m/z [M + Na]
+
 calcd for C23H29NNaO8 470.1785, found 470.1770. 
Compound 11a: [α]  −15.4 (c 1.3, CHCl3); 
1
H NMR (CDCl3, 500 MHz) major 
conformer: δ 7.38−7.24 (5H, H-aromatic), 6.67 (s, 1H, H-6), 4.91 (d, 1H, J2,3 = 9.7 Hz, 
H-2), 4.80 (m, 1H, H-1’), 4.37 (d, 1H, J3a,6a = 7.0 Hz, H-6a), 4.27 (dd, 1H, J1’,2’x = 2.8, 
J2’x,2’y = 12.3 Hz, H-2’x), 4.17 (dd, 1H, J3a,4x = 5.6, J4x,4y = 9.6 Hz, H-4x), 4.05 (dd, 1H, 
J1’,2’y = 4.2, J2’x,2’y = 12.3 Hz, H-2’y), 3.99 (t, 1H, J3a,4y = J4x,4y = 9.6 Hz, H-4y), 3.31 (m, 
1H, J3,3a ~ 8.0, J3a,4x = 5.6, J3a,4y = 9.6, J3a,6a = 7.0 Hz, H-3a), 3.11 (dt, J2,3 = 9.7, J3,3a ~ 
J1’,3 ~ 8.0 Hz, H-3), 2.10 (×2), 1.80 (3s, 9H, CH3CO), 1.12 (br s, 9H, (CH3)3CO); minor 
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conformer (selected signals): 6.65 (s, H-6), 5.06 (d, J2,3 = 9.7 Hz, H-2), 4.28 
(overlapped with H-2’x major, H-6a), 1.40 (br s, (CH3)3CO) ; δ 
13
C NMR (CDCl3, 
125.7 MHz) major conformer: δ 170.7, 169.9, 169.5 (MeCO), 154.3 (NCO2), 
139.6−127.3 (C-aromatic), 100.1 (C-6), 80.8 (C(CH3)), 69.9 (C-1’), 68.5 (C-4), 68.3 (C-
6a), 64.2 (C-2), 63.6 (C-2’), 44.0 (C-3), 42.2 (C-3a), 28.0 (C(CH3)3), 20.9, 20.7 (×2) 
(CH3CO); minor conformer (selected signals): 100.7 (C-6), 68.8 (C-6a), 64.0 (C-2), 
28.4 (C(CH3)3). HRMS (ESI) m/z [M + Na]
+ 
calcd for C25H33NNaO9 514.2047, found 
514.2031. 
 
(2S,3R,3aS,6aR)-1-(tert-butyloxycarbonyl)-3-(1'(R),2'-diacetoxyethyl)-6-oxo-2-
phenylhexahydro-1H-furo[3,4-b]pyrrole (10b) and (2S,3R,3aS,6aR)-1-(tert-
butyloxycarbonyl)-3-(1'(R),2'-diacetoxyethyl)-6-acetoxy-2-phenylhexahydro-1H-
furo[3,4-b]pyrrole (11b) 
Compound 7b (90 mg; 0.22 mmol) was dissolved in anhydrous EtOH and NaBH4 was 
added, as described before for compound 7a. In this case, the mixture was stirred at 0 
°C for 30 min, neutralized with AcOH and concentrated. The residue was redissolved in 
EtOH (10 mL) and the solvent evaporated. The crude mixture was acetylated by 
addition of anhydrous pyridine (2 mL) and acetic anhydride (2 mL) at 0 °C. The 
solution was stirred for 16 h, when TLC (toluene: EtOAc, 7:3) showed two spots of Rf = 
0.30 and 0.18 corresponding respectively to 11b and 10b. This mixture was subjected to 
the usual work up. 
Compound 10b (44 mg, 45%, two steps); [α]  +44.1 (c 0.7, CHCl3); identical 
1
H and 
13
C NMR spectra as 10a; HRMS (ESI) m/z [M + Na]
+
 calcd for C23H29NNaO8 
470.1785, found 470.1789. 
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Compound 11b (6 mg, 6%, two steps); [α]  +15.0 (c 0.9, CHCl3); identical 
1
H and 
13
C 
NMR spectra as 11a; HRMS (ESI) m/z [M + Na]
+
 calcd for C25H33NNaO9 514.2047, 
found 514.2038. 
 
(2S,3R,4S,5R)-1-(tert-butyloxycarbonyl)-4-(1'(S),2'-dihydroxyethyl)-2,3-
bis(hydroxymethyl)-5-phenylpyrrolidine (12a): Compound 7a (50 mg, 0.12 mmol) 
and NaBH4 (14 mg, 0.36 mmol) were dissolved in anhydrous EtOH (2 mL) and the 
mixture was heated under stirring in a sealed vial under N2, at 80 °C for 5 h. The 
mixture was neutralized with AcOH and concentrated. The residue was dissolved in 
EtOH (10 mL), followed by evaporation of the solvent. The same procedure was 
conducted using toluene (10 mL). The resulting residue was purified by column 
chromatography (EtOAc) to give 12a (37 mg, 82%) as a colorless syrup; Rf = 0.10 
(EtOAc); [α]  −32.7 (c 1.4, EtOH); 
1
H NMR (DMSO, 500 MHz) δ 7.30−7.18 (5H, H-
aromatic), 4.89 (dd, 1H, J4,5 = 8.2 Hz, H-5), 4.15 (dd, 1H, J2,4’x = 4.3, J4’x,4’y = 10.7 Hz, 
H-4’x), 3.91 (ddd, 1H, J2,3 = 7.3, J2,4’x = 4.3, J2,4’y = 8.6 Hz, H-2), 3.79 (dd, 1H, J2,4’y = 
8.6, J4’x,4’y = 10.7 Hz, H-4’y), 3.67−3.60 (m, 2H, H-2’x, H-3’x), 3.46 (m, 1H, H-3’y), 
3.41 (dd, 1H, J1’,2’y = 4.2, J2’x,2’y = 10.6 Hz, H-2’y), 3.28 (m, 1H, H-1’), 2.62 (m, 1H, J2,3 
~ J3,3’x ~ J3,3’y ~ J3,4 ~ 7.0 Hz, H-3), 2.49 (m, 1H, H-4), 1.15 (s, 9H, (CH3)3CO); 
13
C 
NMR (DMSO, 125.7 MHz) δ 154.7 (NCO2), 140.9−126.5 (C-aromatic), 79.2 (C(CH3)), 
68.7 (C-1’), 65.5 (C-2’), 63.2 (C-5), 62.0 (C-2), 60.0 (C-4’), 57.6 (C-3’), 47.0 (C-4), 
44.9 (C-3), 27.9 (C(CH3)3); HRMS (ESI) m/z [M + Na]
+
 calcd for C19H29NNaO6 
390.1887, found 390.1881. 
 
(2R,3S,4R,5S)-1-(tert-butyloxycarbonyl)-4-(1’(R),2’-dihydroxyethyl)-2,3-
bis(hydroxymethyl)-5-phenylpyrrolidine (12b): The procedure described for the 
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reduction of 7a (NaBH4, 80 °C, 5 h) was applied to 7b (50 mg, 0.12 mmol) to afford 
compound 12b (31 mg, 69%); [α]  +30.0 (c 1.4, EtOH); HRMS (ESI) m/z [M + Na]
+
 
calcd for C19H29NNaO6 390.1887, found 390.1881. 
 
(2S,3R,4S,5R)-4-(1’(S),2’-diacetoxyethyl)-2,3-bis(acetoxymethyl)-1-(tert-
butyloxycarbonyl)-5-phenylpyrrolidine (13a): Compound 7a (50 mg, 0.12 mmol) 
was reduced with NaBH4, as indicated in the previous item. The crude product was 
dissolved in anhydrous pyridine (1 mL) and Ac2O (1 mL) was added. The mixture was 
stirred at rt for 16 h, cooled to 0 °C and MeOH (10 mL) was added. The residue 
obtained upon concentration was purified by column chromatography (hexane:EtOAc, 
7:3) to give compound 13a as a white solid (53 mg, 81%), mp = 136−137 °C (from 
EtOH:H2O); Rf = 0.10 (hexane:EtOAc, 7:3); [α]  −11.9 (c 1.0, CHCl3); 
1
H NMR 
(CDCl3, 500 MHz) δ 7.30−7.21 (5H, H-aromatic), 5.04 (d, 1H, J4,5 = 6.9 Hz, H-5), 5.02 
(m, 1H, J2,3 = 7.4, J2,4’x = 3.5, J2,4’y = 5.2 Hz, H-2), 4.68 (dd, 1H, J1’,2’x = 3.3, J2’x,2’y = 
11.3 Hz, H-2’x), 4.60 (dd, 1H, J1’,2’y = 7.3, J2’x,2’y = 11.3 Hz, H-2’y), 4.27 (dd, 1H, J2,4’x 
= 3.5, J4’x,4’y = 12.0 Hz, H-4’x), 4.26−4.20 (m, 3H, H-3’x, H-3’y, H-1’), 3.81 (dd, 1H, 
J2,4’y = 5.2, J4’x,4’y = 12.0 Hz, H-4’y), 2.93 (m, 1H, J3,4 = 7.5, J4,5 = 6.9, J1’,4 = 7.8 Hz, H-
4), 2.90 (m, 1H, J2,3 = 7.4, J3,4 = 7.5 Hz, H-3), 2.10, 2.03, 1.97, 1.80 (4s, 12H, CH3CO), 
1.21 (s, 9H, (CH3)3CO); 
13
C NMR (CDCl3, 125.7 MHz) δ 170.5 (×2), 169.7 (MeCO), 
155.0 (NCO2), 139.7−126.7 (C-aromatic), 80.7 (C(CH3)), 68.9, 64.1 (C-2, 5), 64.0 (C-
4’), 62.7 (C-2’), 61.4, 58.7 (C-1’, 3’), 44.4 (C-4), 42.4 (C-3), 28.1 (C(CH3)3), 21.0, 20.9 
(×2), 20.8 (CH3CO); HRMS (ESI) m/z [M + Na]
+
 calcd for C27H37NNaO10 558.2310, 
found 558.2299. 
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(2R,3S,4R,5S)-4-(1’(R),2’-diacetoxyethyl)-2,3-bis(acetoxymethyl)-1-(tert-
butyloxycarbonyl)-5-phenylpyrrolidine (13b): The reduction and acetylation 
conditions reported for 7a were employed starting from 7b (50 mg, 0.12 mmol) to 
afford compound 13b as a white solid (50 mg, 76%), mp = 136 °C (from EtOH:H2O); 
[α]  +10.8 (c 1.1, CHCl3); identical 
1
H and 
13
C NMR spectra as 13a; HRMS (ESI) m/z 
[M + Na]
+
 calcd for C27H37NNaO10 558.2310, found 558.2305. 
 
(2S,3R,4S,5R)-4-(1'(S),2'-dihydroxyethyl)-2,3-bis(hydroxymethyl)-5-
phenylpyrrolidine (14): Compound 6a (41 mg, 0.13 mmol) and NaBH4 (14 mg, 0.38 
mmol) were dissolved in anhydrous EtOH (2 mL) and the mixture was heated under 
stirring in a sealed vial under N2, at 80 °C for 5 h, as described before for 12a. After the 
same work up, the residue was purified by column chromatography (EtOAc:MeOH, 
4:1) to give 14 (19 mg, 53%) as a colorless syrup; Rf = 0.17 (MeOH:EtOAc, 6:4); [α]  
+39.7 (c 0.9, MeOH); 
1
H NMR (MeOD, 500 MHz) δ 7.52−7.34 (5H, H-aromatic), 4.61 
(d, 1H, J4,5 = 8.1 Hz, H-5), 4.06 (dd, 1H, J3,3’x = 6.1, J3’x,3’y = 10.7 Hz, H-3’x), 4.02 (dd, 
1H, J2,4’x = 5.6, J4’x,4’y = 11.5 Hz, H-4’x), 3.98 (dd, 1H, J2,4’y = 7.9, J4’x,4’y = 11.5 Hz, H-
4’y), 3.91 (dd, 1H, J3,3’y = 4.8, J3’x,3’y = 10.7 Hz, H-3’y), 3.69 (dt, 1H, J2,3 = 7.3, J2,4’x = 
5.6, J2,4’y = 7.9 Hz, H-2), 3.58 (dt, 1H, J1,2’x = 4.1, J1,2’y = J1’,4 = 6.5 Hz, H-1’), 3.20 (dd, 
1H, J1’,2’x = 4.1, J2’x,2’y = 11.4 Hz, H-2’x), 3.11 (dd, 1H, J1’,2’y = 6.5, J2’x,2’y = 11.4 Hz, H-
2’y), 2.85−2.78 (m, 2H, H-3, H-4); 
13
C NMR (MeOD, 125.7 MHz) δ 137.5−127.3 (C-
aromatic), 71.5 (C-1’), 65.7 (C-2’), 65.2 (C-5), 63.5 (C-2), 61.0 (C-4’), 59.6 (C-3’), 
46.6, 45.5 (C-3, 4); HRMS (ESI) m/z [M + H]
+
 calcd for C14H22NO4 268.1543, found 
268.1540. 
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Hydrolysis of the N-Boc protecting group of 12a and 12b. 
A solution of 12a or 12b (0.08 mmol) in TFA (2 mL) was stirred at rt for 16 h. 
Monitoring by TLC (EtOAc) showed conversion of the starting material into a more 
polar product (Rf = 0). The solution was concentrated in vacuum and residue was 
dissolved in toluene (10 mL) followed by evaporation of the solvent. After the same 
treatment with methanol (10 mL), compounds 15a or 15b (from 12a or 12b, 
respectively) were obtained.  
(2S,3R,4S,5R)-4-(1’(S),2’-dihydroxyethyl)-2,3-bis(hydroxymethyl)-5-
phenylpyrrolidinium trifluoroacetate (15a): colorless syrup (27 mg, 93%), [α]  
+56.0 (c 1.4, MeOH); 
1
H NMR (D2O, 500 MHz) δ 7.58−7.49 (5H, H-aromatic), 4.88 (d, 
1H, J4,5 = 10.0 Hz, H-5), 4.16 (dd, 1H, J2,4’x = 4.9, J4’x,4’y = 12.2 Hz, H-4’x), 4.12 (dd, 
1H, J3,3’x = 5.5, J3’x,3’y = 11.3 Hz, H-3’x), 4.11 (dd, 1H, J2,4’y = 8.9, J4’x,4’y = 12.2 Hz, H-
4’y), 3.97 (dd, 1H, J3,3’y = 4.3, J3’x,3’y = 11.3 Hz, H-3’y), 3.94 (m, 1H, J2,3 = 7.3, J2,4’x = 
4.9, J2,4’y = 8.9 Hz, H-2), 3.78 (m, 1H, J1’,2’x = 3.1, J1’,2’y = 6.8, J1’,4 = 8.5 Hz, H-1’), 
3.15 (dd, 1H, J1’,2’x = 3.1, J2’x,2’y = 12.0 Hz, H-2’x), 3.05 (dd, 1H, J1’,2’y = 6.8, J2’x,2’y = 
12.0 Hz, H-2’y), 3.04 (dt, 1H, J1’,4 = 8.5, J3,4 = 7.6, J4,5 = 10.0 Hz, H-4), 2.90 (m, 1H, 
J2,3 = 7.3, J3,3’x = 5.5, J3,3’y = 4.3, J3,4 = 7.6, Hz, H-3); 
13
C NMR (D2O, 125.7 MHz) δ 
132.4−128.5 (C-aromatic), 69.7 (C-1’), 64.0 (C-2’), 63.1 (C-5), 62.8 (C-2), 58.4 (C-4’), 
57.6 (C-3’), 43.6 (C-4), 42.4 (C-3); HRMS (ESI) m/z [M + H]
+
 calcd for C14H22NO4 
268.1543, found 268.1548.  
(2R,3S,4R,5S)-4-(1’(R),2’-dihydroxyethyl)-2,3-bis(hydroxymethyl)-5-
phenylpyrrolidinium trifluoroacetate (15b): colorless syrup (29 mg, 99%), [α]  
−54.1 (c 1.4, MeOH); identical 
1
H and 
13
C NMR spectra as 15a; HRMS (ESI) m/z [M + 
H]
+
 calcd for C14H22NO4 268.1543, found 268.1544.  
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Degradative oxidation of the 1,2-ethanediol moiety of 12a and 12b. 
 
(1R,3aR,4S,6R,6aS)-5-(tert-butyloxycarbonyl)-4-(hydroxymethyl)-6-
phenylhexahydro-1H-furo[3,4-c]pyrrol-1-ol (16a): To a solution of 12a (28 mg, 0.08 
mmol) in anhydrous EtOH (2 mL) was added NaIO4 (50 mg, 0.22 mmol). The mixture 
was stirred at rt for 8 h, when TLC showed a main spot of Rf = 0.40 (toluene:EtOH, 
4:1). The mixture was diluted with EtOAc (10 mL), filtered and concentrated. Column 
chromatography with hexane:EtOAc 3:7 gave 16a white solid, (23 mg, 90%), mp = 
147−148 °C (from EtOH:H2O); [α]  +10.6 (c 1.1, CHCl3); 
1
H NMR (CDCl3, 500 
MHz) δ 7.33−7.19 (5H, H-aromatic), 5.18 (d, 1H, J6,6a = 10.0 Hz, H-6), 4.77 (d, 1H, J1,6a 
= 2.1 Hz, H-1), 4.23 (ddd, 1H, J3a,4 = 8.8, J4,4’x = 4.5, J4,4’y = 6.5 Hz, H-4), 4.05 (dd, 1H, 
J3a,3x = 6.2, J3x,3y = 9.7 Hz, H-3x), 3.97 (dd, 1H, J3a,3y = 2.8, J3x,3y = 9.7 Hz, H-3y), 
3.89−3.86 (m, 2H, H-4’x, H-4’y), 3.26 (m, 1H, J3a,3x = 6.2, J3a,3y = 2.8, J3a,4 = 8.8, J3a,6a 
= 8.4 Hz, H-3a), 3.15 (m, 1H, J1,6a = 2.1, J3a,6a = 8.4, J6,6a = 10.0 Hz, H-6a), 1.15 (s, 9H, 
(CH3)3CO); 
13
C NMR (CDCl3, 125.7 MHz) δ 156.7 (NCO2), 140.7−126.1 (C-aromatic), 
99.9 (C-1), 81.2 (C(CH3)), 67.6 (C-3), 64.7 (C-4’), 63.6 (C-6), 62.5 (C-4), 56.1 (C-6a), 
45.3 (C-3a), 28.0 (C(CH3)3); HRMS (ESI) m/z [M + Na]
+
 calcd for C18H25NNaO5 
358.1625, found 358.1614. 
 
(1S,3aS,4R,6S,6aR)-5-(tert-butyloxycarbonyl)-4-(hydroxymethyl)-6-
phenylhexahydro-1H-furo[3,4-c]pyrrol-1-ol (16b): The periodate oxidation of 12b 
(15 mg, 0.04 mmol) was conducted as described above to give 16b as a white solid (13 
mg, 95%), mp = 146−147 °C (from EtOH:H2O); [α]  −9.5 (c 1.0, CHCl3); identical 
1
H 
and 
13
C NMR spectra as 16a; HRMS (ESI) m/z [M + Na]
+ 
calcd for C18H25NNaO5 
358.1625, found 358.1616. 
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 (2S,3R,4S,5R)-1-(tert-butyloxycarbonyl)-2,3,4-tris(hydroxymethyl)-5-
phenylpyrrolidine (17a): The crude hemiacetal 16a, obtained from 12a (22 mg, 0.06 
mmol) was dissolved in anhydrous EtOH (2 mL) and NaBH4 (6.7 mg, 0.17 mmol) was 
added. The solution was stirred at rt for 2 h and then neutralized with AcOH and 
concentrated. The residue was dissolved in EtOH (10 mL) followed by evaporation of 
the solvent. After the same treatment with toluene (10 mL), the residue was subjected to 
column chromatography with EtOAc to give compound 17a (19 mg, 94%) as a 
colorless syrup; Rf = 0.20 (toluene:EtOH, 4:1); [α]  +12.9 (c 1.0, EtOH); 
1
H NMR 
(CDCl3, 500 MHz) δ 7.28−7.08 (5H, H-aromatic), 4.94 (d, 1H, J4,5 = 7.9 Hz, H-5), 4.13 
(ddd, 1H, J2,3 = 7.8, J2,4’x = 7.1, J2,4’y = 6.1 Hz, H-2), 3.94 (dd, 1H, J2,4’x = 7.1, J4’x,4’y = 
11.0 Hz, H-4’x), 3.82 (dd, 1H, J2,4’y = 6.1, J4’x,4’y = 11.0 Hz, H-4’y), 3.79−3.76 (d, 2H, 
J3,3’x = J3,3’y = 6.0 Hz, H-3’x, H-3’y), 3.37 (dd, 1H, J1’x,4 = 10.1, J1’x,1’y = 11.3 Hz, H-
1’x), 3.05 (dd, 1H, J1’y,4 = 4.6, J1’x,1’y = 11.3 Hz, H-1’y), 2.72 (m, 1H, J2,3 = J3,4 = 7.8, 
J3,3’x = J3,3’y = 6.0 Hz, H-3), 2.68 (m, 1H, J1’x,4 = 10.1, J1’y,4 = 4.6, J3,4 = 7.8, J4,5 = 7.9 
Hz, H-4), 1.05 (s, 9H, (CH3)3CO); 
13
C NMR (CDCl3, 125.7 MHz) δ 156.9 (NCO2), 
140.2−126.0 (C-aromatic), 80.9 (C(CH3)), 64.8 (C-5), 64.0 (C-2), 62.3 (C-4’), 61.7 (C-
1’), 59.1 (C-3’), 46.6 (C-4), 45.5 (C-3), 27.9 (C(CH3)3); HRMS (ESI) m/z [M + Na]
+
 
calcd for C18H27NNaO5 360.1781, found 360.1789. 
 
(2R,3S,4R,5S)-1-(tert-butyloxycarbonyl)-2,3,4-tris(hydroxymethyl)-5-
phenylpyrrolidine (17b): The NaBH4 reduction of 16b, obtained from 12b (78 mg, 
0.21 mmol) was conducted as already described for the analogue 16a. Column 
chromatography with EtOAc gave compound 17b (59 mg, 82%); [α]  −14.1 (c 1.0, 
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EtOH); identical 
1
H and 
13
C NMR spectra as 17a; HRMS (ESI) m/z [M + Na]
+
 calcd for 
C18H27NNaO5 360.1781, found 360.1768. 
 
Hydrolysis of the N-Boc protecting group of 17a and 17b 
 
Hydrolysis of compounds 17a or 17b (34 mg, 0.10 mmol) with TFA (2 mL) at rt for 16 
h afforded, after the usual work-up, the respective trifluoroacetates 18a or 18b.  
 
(2S,3R,4S,5R)-2,3,4-tris(hydroxymethyl)-5-phenylpyrrolidinium trifluoroacetate 
(18a): colorless syrup (34 mg, 96%), [α]  +66.3 (c 1.0, MeOH); 
1
H NMR (D2O, 500 
MHz) δ 7.41−7.34 (5H, H-aromatic), 4.81 (d, 1H, J4,5 = 7.2 Hz, H-5), 4.03−3.98 (m, 3H, 
H-2, H-4’x, H-4’y), 3.82 (dd, 1H, J3,3’x = 6.5, J3’x,3’y = 11.3 Hz, H-3’x), 3.79 (dd, 1H, 
J3,3’y = 6.6, J3’x,3’y = 11.3 Hz, H-3’y), 3.47 (dd, 1H, J1’x,4 = 3.0, J1’x,1’y = 11.6 Hz, H-1’x), 
3.36 (dd, 1H, J1’y,4 = 4.2, J1’x,1’y = 11.6 Hz, H-1’y), 2.98 (m, 1H, J2,3 = 9.4, J3,4 = 8.1, 
J3,3’x = 6.5, J3,3’y = 6.6 Hz, H-3), 2.82 (m, 1H, J3,4 = 8.1, J4,5 = 7.2, J1’x,4 = 3.0, J1’y,4 = 4.2 
Hz, H-4); 
13
C NMR (D2O, 125.7 MHz) δ 162.4 (q, J = 36.0 Hz, F3CCO), 131.7−126.7 
(C-aromatic), 116.0 (q, J = 291.0 Hz, F3CCO), 64.2 (C-5), 61.7, 58.0 (C-2, 4’), 57.4 (C-
3’), 57.1 (C-1’), 43.6 (C-4), 41.1 (C-3); HRMS (ESI) m/z [M + H]
+
 calcd for 
C13H20NO3 238.1438, found 238.1430. 
 
(2R,3S,4R,5S)-2,3,4-tris(hydroxymethyl)-5-phenylpyrrolidinium trifluoroacetate 
(18b): colorless syrup (34 mg, 96%), [α]  −68.2 (c 1.0, MeOH); the 
1
H and 
13
C NMR 
spectra were identical to those of 18a; HRMS (ESI) m/z [M + H]
+
 calcd for C13H20NO3 
238.1438, found 238.1431. 
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Enzymatic assays 
The inhibition studies were performed by Professor Carla Marino, who had isolated the 
enzyme.
24,25
 The enzymatic activity was assayed using the filtered medium of a 
stationary culture of P. fellutanum as source of exo β-D-galactofuranosidase and 4-
nitrophenyl β-D-galactofuranoside as substrate. The standard assay was conducted with 
50 µL of 66 mM NaOAc buffer (pH4.6), 20 µL of a 5 mM solution of 4-nitrophenyl β-
D-galactofuranoside and 20 µL (4 µg protein) of the enzyme medium, in a final volume 
of 250 µL. Compounds 14, 15a, 15b, 18a and 18b were incorporated in the amounts 
required to obtain a final concentration of 0.1 to 1.6 mM. The enzymatic reaction was 
stopped after 1.5 h of incubation at 37 ºC by addition of 1mL of 0.1 M Na2CO3 buffer 
(pH 9.0). The 4-nitrophenol released was measured spectrophotometrically at 410 nm.  
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